GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Invitro International (OTCPK:IVRO) » Definitions » EBIT

Invitro International (Invitro International) EBIT : $-0.92 Mil (TTM As of Jun. 2097)


View and export this data going back to 1991. Start your Free Trial

What is Invitro International EBIT?

Invitro International's earnings before interest and taxes (EBIT) for the three months ended in Jun. 2097 was $-0.20 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2097 was $-0.92 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Invitro International's annualized ROC % for the quarter that ended in Jun. 2097 was -94.76%. Invitro International's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2097 was -125.23%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Invitro International's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2097 was -58.46%.


Invitro International EBIT Historical Data

The historical data trend for Invitro International's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invitro International EBIT Chart

Invitro International Annual Data
Trend Feb90 Feb91 Sep92 Sep93 Sep94 Sep95 Sep96
EBIT
Get a 7-Day Free Trial -5.30 -3.50 -4.60 -3.00 -2.00

Invitro International Quarterly Data
Sep92 Dec92 Mar93 Jun93 Sep93 Dec93 Mar94 Jun94 Sep94 Dec94 Mar95 Jun95 Sep95 Dec95 Mar96 Jun96 Sep96 Dec96 Mar97 Jun97
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.36 -0.62 0.30 -0.40 -0.20

Competitive Comparison of Invitro International's EBIT

For the Diagnostics & Research subindustry, Invitro International's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invitro International's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Invitro International's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Invitro International's EV-to-EBIT falls into.



Invitro International EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2097 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.92 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Invitro International  (OTCPK:IVRO) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Invitro International's annualized ROC % for the quarter that ended in Jun. 2097 is calculated as:

ROC % (Q: Jun. 2097 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2097 ) + Invested Capital (Q: Jun. 2097 ))/ count )
=-0.804 * ( 1 - 0% )/( (0.842 + 0.855)/ 2 )
=-0.804/0.8485
=-94.76 %

where

Note: The Operating Income data used here is four times the quarterly (Jun. 2097) data.

2. Joel Greenblatt's definition of Return on Capital:

Invitro International's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2097 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2097 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2097  Q: Jun. 2097
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.804/( ( (0.182 + max(0.446, 0)) + (0.161 + max(0.495, 0)) )/ 2 )
=-0.804/( ( 0.628 + 0.656 )/ 2 )
=-0.804/0.642
=-125.23 %

where Working Capital is:

Working Capital(Q: Mar. 2097 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.157 + 0.503 + 0.045) - (0.189 + 0 + 0.07)
=0.446

Working Capital(Q: Jun. 2097 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.175 + 0.486 + 0.027) - (0.127 + 0 + 0.066)
=0.495

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jun. 2097) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Invitro International's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2097 )
=-0.919/1.572
=-58.46 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Invitro International EBIT Related Terms

Thank you for viewing the detailed overview of Invitro International's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Invitro International (Invitro International) Business Description

Traded in Other Exchanges
N/A
Address
330 East Orangethorpe Avenue, Suite D, Placentia, CA, USA, 92870
Invitro International is a provider of non-animal testing methods. The company develops and commercializes test kits and laboratory services. Its testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its products and services include Irritection, Corrositex, and Lab Services. The company provides its products to various industries such as cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation. The majority of its revenue is generated from the United States and it also exports to other countries.